Samsung Could Soon Produce Pfizer S Covid 19 Vaccines
The revelation comes from The Korea Herald (via) which adds that South Korean President Moon Jae-in, who is currently in the U.S., has a meeting with Albert Bourla, the CEO of Pfizer. The report mentions that Samsung Biologics, a biotechnology company under the Samsung Group will take the lead in the company’s vaccine R&D program. This comes after the U.S. and South Korea reached an agreement for joint vaccine development in May 2021....